BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8217533)

  • 1. Chemotherapy for malignant gliomas.
    Kyritsis AP
    Oncology (Williston Park); 1993 Sep; 7(9):93-100; discussion 103, 106. PubMed ID: 8217533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does chemotherapy benefit the patient with a central nervous system glioma?
    Rodriguez LA; Levin VA
    Oncology (Williston Park); 1987 Nov; 1(9):29-36, 40-1. PubMed ID: 3079493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
    Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
    Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of combined modality treatment of malignant gliomas. Comparison of postoperative irradiation, chemotherapy, and combined radio-polychemotherapy (author's transl)].
    Jellinger K; Volc D; Podreka I; Grisold W; Flament H; Vollmer R; Weiss R
    Nervenarzt; 1981 Jan; 52(1):41-50. PubMed ID: 7219613
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary intracranial gliomas: clinical studies and treatment regimens of the Brain Tumor Research Center, University of California, San Francisco, 1977-1979.
    Levin VA; Wilson CB; Vestnys PS
    Cancer Treat Rep; 1981; 65 Suppl 2():83-8. PubMed ID: 7049363
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in the treatment of malignant gliomas.
    Soffietti R; Leoncini B; Rudà R
    Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
    Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
    Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrosourea chemotherapy for primary malignant gliomas.
    Levin VA; Wilson CB
    Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of cerebral tumours: data on malignant gliomas (author's transl)].
    Schiffer D; Giordana MT; Liboni W; Ravetti C; Soffietti R; Tarenzi L; Sannazzari GL; Negri GL
    Riv Patol Nerv Ment; 1978; 99(6):327-42. PubMed ID: 756619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical guidelines for the treatment of malignant gliomas.
    Chamberlain MC; Kormanik PA
    West J Med; 1998 Feb; 168(2):114-20. PubMed ID: 9499745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of high grade malignant gliomas in adults: an overview.
    Brandes A; Soesan M; Fiorentino MV
    Anticancer Res; 1991; 11(2):719-27. PubMed ID: 2064325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for malignant gliomas.
    Forsyth PA; Cairncross JG
    Baillieres Clin Neurol; 1996 Jun; 5(2):371-93. PubMed ID: 8781278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medical management of malignant gliomas].
    Béhin A; Delattre JY
    Cancer Radiother; 2000 Nov; 4 Suppl 1():67s-83s. PubMed ID: 11194966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of malignant glioma: steady progress with multimodal approaches.
    Ashby LS; Ryken TC
    Neurosurg Focus; 2006 Apr; 20(4):E3. PubMed ID: 16709034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemo-radiotherapy for malignant brain tumors].
    Kochi M; Ushio Y
    Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
    J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.